Ciencia e Ingeniería en Alimentos y Biotecnología

URI permanente para esta comunidadhttp://repositorio.uta.edu.ec/handle/123456789/412

Examinar

Resultados de la búsqueda

Mostrando 1 - 3 de 3
  • Item type:Ítem,
    Descripción general de las metodologías de detección y cuantificación de SARS-CoV-2 en muestras clínicas
    (Universidad Técnica de Ambato. Facultad de Ciencia e Ingeniería en Alimentos y Biotecnología. Carrera de Ingeniería Bioquímica, 2022-09)
    Sailema Ronquillo, Wendy Abigail
    ;
    Calero Cáceres, William Ricardo
    At the end of 2019, a new type of coronavirus appeared, known as SARS-CoV-2, which causes the disease COVID-19. This virus spread rapidly and in March 2020 it was declared a pandemic by COVID-19. The most common symptoms of the disease are fever, muscle pain, shortness of breath, cough, loss of smell and taste, headache and diarrhea in 10 percent of infected patients. On the other hand, there are patients who do not present any symptoms, known as asymptomatic patients. Among the critical factors for an adequate response to a viral pandemic, timely detection and isolation of potentially infected individuals are considered first. Thus, the appearance of new variants (alpha, delta, omicron) and the study of the complete genome sequencing of SARS-CoV-2 allowed the development of new molecular analysis technologies. The main objective of this research was to investigate the methodologies for the detection and quantification of SARS-CoV-2. For the development of the study, inclusion and exclusion criteria were proposed, such as: books, articles, documents and reports of scientific bases and research carried out at from the year 2019. As a result, approximately 150 documents were obtained that were analyzed for the present investigation. Specifically, the different technologies available, the types of samples and their processing, SARS-CoV-2 whole genome sequencing techniques, as well as the advantages and limitations of current methods were studied.
  • Item type:Ítem,
    Análisis comparativo de las proteínas espiga de los coronavirus: MERS CoV, SARS CoV y SARS CoV-2 y sus respectivos receptores
    (Universidad Técnica de Ambato. Facultad de Ciencia e Ingeniería en Alimentos y Biotecnología. Carrera de Ingeniería Bioquímica, 2021-03)
    Nauque Villacís, Jason Damian
    ;
    Terán Mera, David Andrés
    At the end of 2019, the discovery of a new coronavirus with the capacity to infect humanswas reported. This coronavirus causes Severe Acute Respiratory Syndrome 2 (SARSCoV- 2). Being the seventh virus of this family that has entered the human being, concern arises about the capacities that these viruses have to adapt to new hosts. This is how the spike proteins of hCoVs were analyzed, with a main emphasis on those with pathogenic and virulent capacities, without neglecting hCoVs. The spike protein is responsible for receptor recognition, as well as being part of the genome that mutates the most in all CoVs. For this reason, the conserved sites of those hCoVs were analyzed. In the present work, the conserved sites of the receptor binding domains (RBD) were analyzed. A phylogenetic analysis was carried out to determine the proximity with other CoVs of animal origin and hypothesize the CoVs with zoonotic capacity.
  • Item type:Ítem,
    Cribado virtual de inhibidores de la enzima Mpro del virus SARS-CoV-2 empleando librerías de compuestos y homología estructural con proteasas de virus patógenos de animales
    (Universidad Técnica de Ambato. Facultad de Ciencia e Ingeniería en Alimentos y Biotecnología. Carrera de Ingeniería Bioquímica, 2021-01)
    Ramos Aristimbay, María Lisette
    ;
    García Solís, Mario Daniel
    The purpose of this study is to perform virtual screening of SARS-CoV-2 virus Mpro enzyme inhibitors using compound libraries and structural homology with animal pathogenic virus proteases. In response to the present pandemic the world is going through, caused by COVID-19, so it is of paramount importance to search for compounds, which prevent the spread of SARS-CoV-2, with which medicines can be made to curb the contagions of this disease. Since the main protease Mpro is responsible for carrying out the proteolytic processes during the replication of the virus, it has been selected as a target for the search for molecules that inhibit its activity, thus preventing the virus from continuing to multiply. For this, a homology analysis was performed that could identify that this protease is preserved in several species of coronavirus that infect animals, such as those that cause murine hepatitis, swine transmissible gastroenteritis, feline peritonitis, and avian infectious bronchitis. Which allowed us to look for compounds used to treat these diseases, and to create a library with the most effective ligands. This was able to determine the druggable sites of the enzyme and perform a molecular coupling (docking), identifying ten inhibitors that best bind to Mpro, including Ritonavir, with which, through subsequent in vitro studies, COVID-19 drugs could be generated, and tested in other coronaviruses with which homology exists.